Literature DB >> 30039464

Rapid transient protein production by the coat protein-deficient cucumber mosaic virus vector: non-packaged CMV system, NoPaCS.

Noriho Fukuzawa1, Chikara Masuta2, Takeshi Matsumura3.   

Abstract

KEY MESSAGE: We developed a non-packaged CMV system (NoPaCS) for CMV-agroinfection with a virus-inescapable transgenic plant platform, enabling rapid, high production of a large-sequence target protein. For rapidly producing high levels of a desirable protein, many plant virus vectors have been developed. However, there is always a concern that such recombinant viruses may escape into the environment. Especially for insect-transmissible viruses, certain measures must be taken. We here developed a new cucumber mosaic virus (CMV) RNA 3-based vector that is not transmitted by aphids because we deleted the coat protein (CP) gene responsible for aphid transmission and replaced it with a foreign gene. Transgenic Nicotiana benthamiana plants expressing CMV RNA 1 (CR1Tg) were found to be the most suitable platform for producing a recombinant protein using the CMV vector. By agroinfiltrating CR1Tg plants with the RNA 2 construct and the CMV vector harboring the green fluorescence protein (GFP) gene instead of the CP gene, we achieved a high yield of GFP (e.g., ~ 750 mg/kg FW) throughout the bacteria-infiltrated tissues at 2-3 days after infiltration. Furthermore, with this CMV-agroinfection system, a large gene such as the β-glucuronidase (GUS) gene can be expressed because the viral RNAs are not necessarily encapsidated for replication. The system is designated "non-packaged CMV system (NoPaCS)".

Entities:  

Keywords:  Agroinfection; Aphid; Cucumber mosaic virus; Plant-based platform; Transgenic plant; Virus vector

Mesh:

Substances:

Year:  2018        PMID: 30039464     DOI: 10.1007/s00299-018-2322-5

Source DB:  PubMed          Journal:  Plant Cell Rep        ISSN: 0721-7714            Impact factor:   4.570


  27 in total

1.  Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.

Authors:  Larry Zeitlin; James Pettitt; Corinne Scully; Natasha Bohorova; Do Kim; Michael Pauly; Andrew Hiatt; Long Ngo; Herta Steinkellner; Kevin J Whaley; Gene G Olinger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Dissecting RNA silencing in protoplasts uncovers novel effects of viral suppressors on the silencing pathway at the cellular level.

Authors:  Yijun Qi; Xuehua Zhong; Asuka Itaya; Biao Ding
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

3.  Development of Cucumber mosaic virus as a vector modifiable for different host species to produce therapeutic proteins.

Authors:  Kouki Matsuo; Jin-Sung Hong; Noriko Tabayashi; Akira Ito; Chikara Masuta; Takeshi Matsumura
Journal:  Planta       Date:  2006-07-05       Impact factor: 4.116

4.  Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants.

Authors:  Sylvestre Marillonnet; Carola Thoeringer; Romy Kandzia; Victor Klimyuk; Yuri Gleba
Journal:  Nat Biotechnol       Date:  2005-05-08       Impact factor: 54.908

5.  Virion stability and aphid vector transmissibility of Cucumber mosaic virus mutants.

Authors:  James C K Ng; Caroline Josefsson; Anthony J Clark; Alexander W E Franz; Keith L Perry
Journal:  Virology       Date:  2005-02-05       Impact factor: 3.616

6.  Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.

Authors:  Gene Garrard Olinger; James Pettitt; Do Kim; Cara Working; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael Pauly; Kevin J Whaley; Calli M Lear; Julia E Biggins; Corinne Scully; Lisa Hensley; Larry Zeitlin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

7.  Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail.

Authors:  James Pettitt; Larry Zeitlin; Do H Kim; Cara Working; Joshua C Johnson; Ognian Bohorov; Barry Bratcher; Ernie Hiatt; Steven D Hume; Ashley K Johnson; Josh Morton; Michael H Pauly; Kevin J Whaley; Michael F Ingram; Ashley Zovanyi; Megan Heinrich; Ashley Piper; Justine Zelko; Gene G Olinger
Journal:  Sci Transl Med       Date:  2013-08-21       Impact factor: 17.956

8.  The C-terminal 33 amino acids of the cucumber mosaic virus 3a protein affect virus movement, RNA binding and inhibition of infection and translation.

Authors:  Sang Hyon Kim; Natalia O Kalinina; Igor Andreev; Eugene V Ryabov; Alexander G Fitzgerald; Michael E Taliansky; Peter Palukaitis
Journal:  J Gen Virol       Date:  2004-01       Impact factor: 3.891

9.  Bipartite and tripartite Cucumber mosaic virus-based vectors for producing the Acidothermus cellulolyticus endo-1,4-β-glucanase and other proteins in non-transgenic plants.

Authors:  Min Sook Hwang; Benjamin E Lindenmuth; Karen A McDonald; Bryce W Falk
Journal:  BMC Biotechnol       Date:  2012-09-21       Impact factor: 2.563

10.  Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Authors:  Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger
Journal:  Nature       Date:  2014-08-29       Impact factor: 49.962

View more
  1 in total

1.  Role of salicylic acid glucosyltransferase in balancing growth and defence for optimum plant fitness.

Authors:  Yudai Kobayashi; Noriho Fukuzawa; Ayaka Hyodo; Hangil Kim; Shota Mashiyama; Tsuyoshi Ogihara; Hirofumi Yoshioka; Hideyuki Matsuura; Chikara Masuta; Takeshi Matsumura; Minoru Takeshita
Journal:  Mol Plant Pathol       Date:  2020-01-21       Impact factor: 5.663

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.